ArticleJournal of translational internal medicine2026

Focal adhesion kinase inhibition enhances response to checkpoint immunotherapy in hepatocellular carcinoma.

Xinyu Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.